A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy
Status:
Completed
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, open label, pilot futility clinical trial of the safety,
tolerability, pharmacodynamics and preliminary efficacy of oral salsalate in up to 10
patients with PSP.